Temporomandibular joint disorder (TMJ) affects as many as 40 million Americans1, yet many treatments fail to address its complex, multi-system origin. At The Center for Transformative Dentistry in ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...